telbivudine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, CW; Huang, YH; Lin, YH; Yeh, CT | 1 |
1 other study(ies) available for telbivudine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Reduction of ACE2 Serum Concentrations by Telbivudine in Chronic Hepatitis B Patients.
Topics: Angiotensin-Converting Enzyme 2; COVID-19; Hepatitis B, Chronic; Humans; Peptidyl-Dipeptidase A; Protein Binding; Retrospective Studies; SARS-CoV-2; Telbivudine | 2023 |